FDA Approves First FXIa Inhibitor for Stroke PreventionNovember 9, 2026 Health 2 Views The FDA approved Sunharbo (asundexian) to help prevent recurrent stroke in adults at high risk, offering a new treatment option alongside existing antiplatelet therapies.
